Susan E. Dubé

Susan E. Dubé

Director/Board Member at
La Jolla Playhouse, Inc.
77 year
Health Technology
Consumer Services
Health Services

Profile

Susan E.
Dubé
was the founder of Somaxon Pharmaceuticals, Inc. (2003) as Senior Vice President-Corporate Development.
Ms. Dubé is also the founder of Sorriso Pharmaceuticals, Inc. Ms. Dubé is currently a Trustee at La Jolla Playhouse, Inc. Former positions include Chief Executive Officer at Biointerventions, Inc., Consultant at Cypress Bioscience, Inc., Chief Operating Officer & Executive Vice President at Cytyc Prenatal Products Corp., SVP-Strategy & Corporate Development at Imagyn Medical Technologies, Inc. (1997-1998), Senior Vice President-Corporate Development at Women First HealthCare, Inc. (1998-2002), Acting Chief Business Officer at BrainCells, Inc., Vice President-Marketing & Corporate Development at Imagyn Medical, Inc., Vice President-Ventures at The Brigham & Women's Hospital, Inc., and VP-Business Development & Administration at Amplyx Pharmaceuticals, Inc. Education includes an MBA from Harvard University and an undergraduate degree from Simmons University.

Susan E. Dubé active positions

CompaniesPositionStart
Director/Board Member -

Former positions of Susan E. Dubé

CompaniesPositionEnd
Founder 01/02/2018
Founder 15/04/2009
Corporate Officer/Principal 01/02/2002
Corporate Officer/Principal 01/06/1998
Chief Administrative Officer -
See the detail of Susan E. Dubé's experience

Training of Susan E. Dubé

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

64

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies14

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Services

Consumer Services

Commercial Services

Biointerventions, Inc.

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Susan E. Dubé
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!